Analyze Diet
Toxicon : official journal of the International Society on Toxinology1994; 32(4); 427-433; doi: 10.1016/0041-0101(94)90294-1

A comparison of ovine and equine antivenoms.

Abstract: Commercial antivenoms produced in horses were compared with monospecific antivenoms raised in sheep against Crotalus durissus terrificus, Crotalus atrox, Crotalus adamanteus, Micrurus fulvius fulvius, Naja naja, Naja kaouthia, Echis ocellatus, Vipera lebetina deserti, Vipera berus berus and Vipera ammodytes ammodytes venom. Antibodies raised by immunizing sheep with C. d. terrificus venom were more effective than their equine counterparts in preventing lethal toxicity in mice (ED50), in inhibiting the venom's pharmacological effects (haemolysis, platelet aggregation and coagulation), and in neutralizing phospholipase A2 activity. Comparison of one ovine and three equine F(ab)2 products raised against V. a. ammodytes venom showed that all were at least 95% pure; that all protected mice; and that all contained antibody populations directed against most components of V. a. ammodytes and V. b. berus venoms. The ovine antivenoms generally contained a higher concentration of specific antibodies than the equine products. Finally, the ovine antivenoms raised against E. ocellatus, V. lebetina deserti, V. b. berus, M. f. fulvius and N. naja venoms provided better in vivo protection to mice than the equine antivenoms, but the equine antivenoms to N. kaouthia and C. atrox were more protective than the ovine product.
Publication Date: 1994-04-01 PubMed ID: 8052997DOI: 10.1016/0041-0101(94)90294-1Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates whether antivenoms produced from sheep blood offer more effective protection against various snake venoms than those produced from horse blood. The results found that, in most cases, ovine (sheep) antivenoms were more effective, with a few exceptions.

Research Methodology

  • The researchers conducted a comparison of commercially produced antivenoms from horse and sheep blood. They specifically investigated the efficacy of these antivenoms against ten types of snake venom from various species.
  • They examined the effectiveness of these antivenoms in preventing lethal toxicity (using the median effective dose or ED50 measure) in mice.
  • Additionally, the researchers studied the ability of these antivenoms to neutralize some of the harmful pharmacological effects of snake venom, such as haemolysis (the breakdown of red blood cells), platelet aggregation (clot formation), and coagulation (clotting).
  • They also compared the capacity of ovine and equine antivenoms to neutralize the activity of phospholipase A2 – an enzyme amplified in snake venom that damages cells and tissues.

Findings

  • Results showed that antibodies obtained through immunizing sheep with C. d. terrificus venom were more effective than their equine counterparts in preventing lethal toxicity in mice, inhibiting venom’s pharmacological effects, and neutralizing phospholilase A2 activity.
  • Further comparison of one ovine and three equine F(ab)2 products (antibody fragments) against V. a. ammodytes venom revealed that all products were at least 95% pure and all provided protection to mice against snake venom.
  • The sheep-generated antivenoms usually contained a greater concentration of specific antibodies than the horse-products.
  • The sheep-made antivenoms against E. ocellatus, V. lebetina deserti, V. b. berus, M. f. fulvius, and N. naja venoms offered better in vivo (in a living organism) protection to mice than horse-produced antivenoms.
  • However, for certain snake venoms (N. kaouthia and C. atrox), the equine antivenoms were more effective in providing protection than ovine antivenoms.

To summarize, the study’s findings suggest that, in general, antivenoms produced from sheep blood appear to be more effective against a variety of snake venoms than those created from horse blood. However, the effectiveness can vary depending on the specific type of venom.

Cite This Article

APA
Sjostrom L, al-Abdulla IH, Rawat S, Smith DC, Landon J. (1994). A comparison of ovine and equine antivenoms. Toxicon, 32(4), 427-433. https://doi.org/10.1016/0041-0101(94)90294-1

Publication

ISSN: 0041-0101
NlmUniqueID: 1307333
Country: England
Language: English
Volume: 32
Issue: 4
Pages: 427-433

Researcher Affiliations

Sjostrom, L
  • Department of Chemical Pathology, Medical College of St Bartholomew's Hospital, London, U.K.
al-Abdulla, I H
    Rawat, S
      Smith, D C
        Landon, J

          MeSH Terms

          • Animals
          • Antibody Formation
          • Antivenins / biosynthesis
          • Antivenins / immunology
          • Antivenins / therapeutic use
          • Dose-Response Relationship, Drug
          • Female
          • Horses
          • Immunoglobulin Fab Fragments
          • Immunoglobulin G
          • Lethal Dose 50
          • Male
          • Mice
          • Phospholipases A / antagonists & inhibitors
          • Phospholipases A2
          • Sheep
          • Snake Venoms / antagonists & inhibitors
          • Snake Venoms / immunology
          • Snake Venoms / toxicity
          • Species Specificity

          Citations

          This article has been cited 7 times.
          1. Pereira EPV, van Tilburg MF, Florean EOPT, Guedes MIF. Egg yolk antibodies (IgY) and their applications in human and veterinary health: A review. Int Immunopharmacol 2019 Aug;73:293-303.
            doi: 10.1016/j.intimp.2019.05.015pubmed: 31128529google scholar: lookup
          2. Stevens NE, Hatjopolous A, Fraser CK, Alsharifi M, Diener KR, Hayball JD. Preserved antiviral adaptive immunity following polyclonal antibody immunotherapy for severe murine influenza infection. Sci Rep 2016 Jul 6;6:29154.
            doi: 10.1038/srep29154pubmed: 27380890google scholar: lookup
          3. Ferreira MG, Duarte CG, Oliveira MS, Castro KL, Teixeira MS, Reis LP, Zambrano JA, Kalapothakis E, Michel AF, Soto-Blanco B, Chávez-Olórtegui C, Melo MM. Toxicity of crude and detoxified Tityus serrulatus venom in anti-venom-producing sheep. J Vet Sci 2016 Dec 30;17(4):467-477.
            doi: 10.4142/jvs.2016.17.4.467pubmed: 27297422google scholar: lookup
          4. Ratanabanangkoon K, Tan KY, Eursakun S, Tan CH, Simsiriwong P, Pamornsakda T, Wiriyarat W, Klinpayom C, Tan NH. A Simple and Novel Strategy for the Production of a Pan-specific Antiserum against Elapid Snakes of Asia. PLoS Negl Trop Dis 2016 Apr;10(4):e0004565.
            doi: 10.1371/journal.pntd.0004565pubmed: 27058956google scholar: lookup
          5. Dixit R, Herz J, Dalton R, Booy R. Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens. Vaccine 2016 Feb 24;34(9):1152-61.
            doi: 10.1016/j.vaccine.2016.01.016pubmed: 26802604google scholar: lookup
          6. Stevens NE, Fraser CK, Alsharifi M, Brown MP, Diener KR, Hayball JD. An empirical approach towards the efficient and optimal production of influenza-neutralizing ovine polyclonal antibodies demonstrates that the novel adjuvant CoVaccine HT™ is functionally superior to Freund's adjuvant. PLoS One 2013;8(7):e68895.
            doi: 10.1371/journal.pone.0068895pubmed: 23894371google scholar: lookup
          7. Heard K, O'Malley GF, Dart RC. Antivenom therapy in the Americas. Drugs 1999 Jul;58(1):5-15.